Published in J Gene Med on September 01, 2005
Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment. PLoS One (2009) 1.46
Vaccination for hepatitis C virus: closing in on an evasive target. Expert Rev Vaccines (2011) 1.37
Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation. J Virol (2008) 1.33
Electrochemotherapy with bleomycin induces hallmarks of immunogenic cell death in murine colon cancer cells. Oncoimmunology (2014) 1.04
Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee. BMC Biotechnol (2006) 0.92
Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and E by DNA electrotransfer. Infect Immun (2009) 0.87
Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers. Hum Vaccin Immunother (2013) 0.84
Design of immunogenic and effective multi-epitope DNA vaccines for melanoma. Cancer Immunol Immunother (2011) 0.82
APOBEC3A intratumoral DNA electroporation in mice. Gene Ther (2016) 0.75
Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol (2007) 1.87
NFAT is a nerve activity sensor in skeletal muscle and controls activity-dependent myosin switching. Proc Natl Acad Sci U S A (2004) 1.56
In vivo electroporation enhances the immunogenicity of hepatitis C virus nonstructural 3/4A DNA by increased local DNA uptake, protein expression, inflammation, and infiltration of CD3+ T cells. J Immunol (2007) 1.50
DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer. Hum Gene Ther (2009) 1.34
Recruitment of antigen-presenting cells to the site of inoculation and augmentation of human immunodeficiency virus type 1 DNA vaccine immunogenicity by in vivo electroporation. J Virol (2008) 1.33
Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen. J Immunol (2005) 1.18
A novel electroporation device for gene delivery in large animals and humans. Vaccine (2005) 1.09
DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8(+) T-cell responses and increases PSA doubling time. Cancer Immunol Immunother (2012) 1.02
DNA electroporation prime and protein boost strategy enhances humoral immunity of tuberculosis DNA vaccines in mice and non-human primates. Vaccine (2005) 0.99
Therapeutic DNA vaccination using in vivo electroporation followed by standard of care therapy in patients with genotype 1 chronic hepatitis C. Mol Ther (2013) 0.96
Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation. Vaccine (2002) 0.94
Updating the lamellar hypothesis of hippocampal organization. Front Neural Circuits (2012) 0.93
Gene expression and immune response kinetics using electroporation-mediated DNA delivery to muscle. J Gene Med (2005) 0.93
Monoclonal antibodies produced by muscle after plasmid injection and electroporation. Mol Ther (2004) 0.93
Activity-dependent plasticity of transmitter release from nerve terminals in rat fast and slow muscles. J Neurosci (2003) 0.91
DNA transfection of mononuclear cells in muscle tissue. J Gene Med (2003) 0.91
A novel role for embigin to promote sprouting of motor nerve terminals at the neuromuscular junction. J Biol Chem (2009) 0.90
Taking electroporation-based delivery of DNA vaccination into humans: a generic clinical protocol. Methods Mol Biol (2008) 0.84
Targeting functional subtypes of spinal motoneurons and skeletal muscle fibers in vivo by intramuscular injection of adenoviral and adeno-associated viral vectors. Anat Embryol (Berl) (2002) 0.81
Development of tonic firing behavior in rat soleus muscle. J Neurophysiol (2008) 0.80
Electrical muscle activity pattern and transcriptional and posttranscriptional mechanisms regulate PKA subunit expression in rat skeletal muscle. Mol Cell Neurosci (2002) 0.77
Synergistic effect of low dose cyclosporine A and human interleukin 10 overexpression on acute rejection in rat lung allotransplantation. Eur J Cardiothorac Surg (2005) 0.77
Green fluorescent protein modified to bind DNA initiates production of anti-DNA antibodies when expressed in vivo. Mol Immunol (2002) 0.76
Nobel Prize in Physiology or Medicine 2014. Tidsskr Nor Laegeforen (2014) 0.75
[DNA--the future in vaccine technology?]. Tidsskr Nor Laegeforen (2006) 0.75